HUP9701060A3 - Pharmaceutical composition containing darifenacin for treating cognitive disturbs - Google Patents
Pharmaceutical composition containing darifenacin for treating cognitive disturbsInfo
- Publication number
- HUP9701060A3 HUP9701060A3 HU9701060A HUP9701060A HUP9701060A3 HU P9701060 A3 HUP9701060 A3 HU P9701060A3 HU 9701060 A HU9701060 A HU 9701060A HU P9701060 A HUP9701060 A HU P9701060A HU P9701060 A3 HUP9701060 A3 HU P9701060A3
- Authority
- HU
- Hungary
- Prior art keywords
- disturbs
- pharmaceutical composition
- composition containing
- treating cognitive
- darifenacin
- Prior art date
Links
- 230000001149 cognitive effect Effects 0.000 title 1
- HXGBXQDTNZMWGS-RUZDIDTESA-N darifenacin Chemical compound C=1C=CC=CC=1C([C@H]1CN(CCC=2C=C3CCOC3=CC=2)CC1)(C(=O)N)C1=CC=CC=C1 HXGBXQDTNZMWGS-RUZDIDTESA-N 0.000 title 1
- 229960002677 darifenacin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612710.5A GB9612710D0 (en) | 1996-06-18 | 1996-06-18 | Method of treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9701060D0 HU9701060D0 (en) | 1997-08-28 |
| HUP9701060A2 HUP9701060A2 (hu) | 1998-12-28 |
| HUP9701060A3 true HUP9701060A3 (en) | 1999-03-29 |
Family
ID=10795468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9701060A HUP9701060A3 (en) | 1996-06-18 | 1997-06-17 | Pharmaceutical composition containing darifenacin for treating cognitive disturbs |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5837724A (hu) |
| EP (1) | EP0813870B1 (hu) |
| JP (1) | JP3453493B2 (hu) |
| KR (1) | KR980000445A (hu) |
| AT (1) | ATE243514T1 (hu) |
| AU (1) | AU2495697A (hu) |
| CA (1) | CA2208111C (hu) |
| DE (1) | DE69722999T2 (hu) |
| DK (1) | DK0813870T3 (hu) |
| ES (1) | ES2197972T3 (hu) |
| GB (1) | GB9612710D0 (hu) |
| HU (1) | HUP9701060A3 (hu) |
| IL (1) | IL121036A0 (hu) |
| PT (1) | PT813870E (hu) |
| ZA (1) | ZA975311B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
| US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
| GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
| JP4767842B2 (ja) * | 2003-04-01 | 2011-09-07 | セラヴァンス， インコーポレーテッド | β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
| MX344177B (es) | 2008-03-27 | 2016-12-08 | Chase Pharmaceuticals Corp | Uso y composicion para tratar la demencia. |
| PL3061821T3 (pl) * | 2009-07-22 | 2020-01-31 | PureTech Health LLC | Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| SG10202113198TA (en) * | 2017-06-01 | 2021-12-30 | Eisai R&D Man Co Ltd | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
| BR112021005802B1 (pt) | 2018-09-28 | 2022-02-15 | Karuna Therapeutics, Inc | Composição farmacêutica oral |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
| GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
-
1996
- 1996-06-18 GB GBGB9612710.5A patent/GB9612710D0/en active Pending
-
1997
- 1997-06-05 PT PT97303879T patent/PT813870E/pt unknown
- 1997-06-05 ES ES97303879T patent/ES2197972T3/es not_active Expired - Lifetime
- 1997-06-05 EP EP97303879A patent/EP0813870B1/en not_active Expired - Lifetime
- 1997-06-05 AT AT97303879T patent/ATE243514T1/de active
- 1997-06-05 DK DK97303879T patent/DK0813870T3/da active
- 1997-06-05 DE DE69722999T patent/DE69722999T2/de not_active Expired - Lifetime
- 1997-06-09 IL IL12103697A patent/IL121036A0/xx unknown
- 1997-06-10 JP JP15189997A patent/JP3453493B2/ja not_active Expired - Lifetime
- 1997-06-11 US US08/872,891 patent/US5837724A/en not_active Expired - Lifetime
- 1997-06-16 CA CA002208111A patent/CA2208111C/en not_active Expired - Lifetime
- 1997-06-17 KR KR1019970025073A patent/KR980000445A/ko not_active Application Discontinuation
- 1997-06-17 ZA ZA975311A patent/ZA975311B/xx unknown
- 1997-06-17 AU AU24956/97A patent/AU2495697A/en not_active Abandoned
- 1997-06-17 HU HU9701060A patent/HUP9701060A3/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3453493B2 (ja) | 2003-10-06 |
| JPH1059848A (ja) | 1998-03-03 |
| US5837724A (en) | 1998-11-17 |
| ZA975311B (en) | 1998-12-17 |
| DE69722999T2 (de) | 2003-12-18 |
| AU2495697A (en) | 1998-01-08 |
| PT813870E (pt) | 2003-10-31 |
| IL121036A0 (en) | 1997-11-20 |
| DK0813870T3 (da) | 2003-08-18 |
| HU9701060D0 (en) | 1997-08-28 |
| CA2208111C (en) | 2002-10-15 |
| GB9612710D0 (en) | 1996-08-21 |
| HUP9701060A2 (hu) | 1998-12-28 |
| EP0813870B1 (en) | 2003-06-25 |
| CA2208111A1 (en) | 1997-12-18 |
| EP0813870A1 (en) | 1997-12-29 |
| ES2197972T3 (es) | 2004-01-16 |
| ATE243514T1 (de) | 2003-07-15 |
| KR980000445A (ko) | 1998-03-30 |
| DE69722999D1 (de) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1022835A1 (en) | Pharmaceutical composition for treatment of diabetes | |
| EP0874828A4 (en) | PAIN TREATMENT COMPOSITIONS | |
| HUP9903544A3 (en) | Pharmaceutical composition with anaesthetic effect for local use | |
| HUP9904261A3 (en) | Hair treatment composition containing metal-aminoacid complex | |
| EP0943327A4 (en) | DRUG | |
| GB9812056D0 (en) | Pharmaceutical composition for treatment of ibd and rbd | |
| EP0803255A4 (en) | DRUG | |
| IL115766A0 (en) | Composition and treatment for multiple sclerosis | |
| HUP9901452A3 (en) | Bicyclic-aromatic compounds and pharmaceutical compositions containing them | |
| HUP9701060A3 (en) | Pharmaceutical composition containing darifenacin for treating cognitive disturbs | |
| IL115843A0 (en) | Pharmaceutical composition containing cisapride-(l)-tartrate | |
| HUP9800396A3 (en) | Pharmaceutical composition for treating dementia | |
| IL124419A0 (en) | Composition for treating pain | |
| IL112469A0 (en) | Composition for the treatment of an epidermal disorder | |
| HU9603158D0 (en) | Pharmaceutical composition for treating glaucoma containing terazosin | |
| GB9623962D0 (en) | Pharmaceutical composition | |
| CZ136095A3 (en) | Spinning apparatus for spindleless spinning | |
| IL120100A (en) | Pharmaceutical compositions containing tetrahydroisoquinolines and some such novel compounds | |
| IL115853A (en) | Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds | |
| HUP9600327A3 (en) | Pharmaceutical composition for treating or profilacting meteoropathy and different kinetoses | |
| GB9626739D0 (en) | Pharmaceutical composition for treating anal incontinence | |
| GB9626750D0 (en) | Pharmaceutical composition for treating anal incontinence | |
| EP0761225A4 (en) | PHARMACEUTICAL PREPARATION FOR TREATING PERIPHERAL BLOOD DISORDERS | |
| PL311159A1 (en) | Pharmaceutical composition for treating psoriasis | |
| ZA977665B (en) | Pharmaceutical composition containing osteogenesis-promoting substance |